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Abstract 
Pore architecture of scaffolds is known to play a critical role in tissue engineering as it 
provides the vital framework for the seeded cells to organize into a functioning tissue. In 
this report, we investigated the effects of different concentrations of silk fibroin protein 
on 3 dimensional (3D) scaffold pore microstructure. Four pore size ranges of silk fibroin 
scaffolds were made by freeze-dry technique, with the pore sizes ranging from 50 to 300 
µm. The pore size of the scaffold decreases as the concentration of fibroin protein 
increases. Human bone marrow mesenchymal stromal cells (BMSCs) transfected with 
BMP7 gene were cultured in these scaffolds. Cell viability Colorimetric assay (MTS), 
alkaline phosphatase （ALP）assay and reverse transcription-polymerase chain reaction 
(RT-PCR) were performed to analyze the effect of the pore size on cell growth, the 
secretion of extracellular matrix (ECM), and osteogenic differentiation. Cell migration in 
3D scaffolds was confirmed by confocal microscopy.  Calvarial defects in SCID mice 
were used to determine the bone forming ability of the silk fibroin scaffolds incorporated 
with BMP7-expressing BMSCs. The results showed that BMP7 expressing BMSCs 
preferred a pore size between 100 and 300 µm of silk fibroin protein fabricated scaffolds, 
with better cell proliferation and ECM production. Furthermore, in vivo transplantation of 
the silk fibroin scaffolds combined with BMP7-expressing BMSCs induced new bone 
formation. This study identified that optimized pore architecture of silk fibroin scaffolds 
could modulate the bioactivities of BMP7 transfected BMSCs in bone formation. 
Key words: bone marrow mesenchymal stromal cell; bone morphogenetic protein; silk 
fibroin scaffold; bone 
1. Introduction 
Tissue engineering is a promising technology that uses cells and biomaterials to replace 
damaged tissues or organs[1,2]. A cell-based tissue engineering technique has proved to 
be one of the most promising alternative therapies for bone defects. This approach 
consists of an interactive triad of responsive cells, a supportive matrix, and bioactive 
molecules promoting differentiation and regeneration. 
 
Bone marrow mesenchymal stromal cells (BMSCs) are a prospective cell source for the 
engineering of bone tissue. They are relatively easy to obtain from a small aspirate of 
bone marrow and have multiple potentials to differentiate into different cell lineages such 
as osteoblasts, chondrocytes, adipose cells, ligament cells, and neural cells [3]. In 
addition, they are relatively easy to expand in culture under conditions in which they 
retain some of their potential to differentiate into multiple cell lineages [4].  
 
Use of bone morphogenetic proteins (BMPs) for bone regeneration represents one of the 
most promising emerging therapies for bone regeneration and is a viable alternative to 
autologous and homologous bone grafts. BMP-7 appears to be one of the most potent 
osteogenic factors for bone regeneration[5]. However, the physiological effects of BMPs 
may not be maximized by direct delivery of recombinant proteins because of their rapid 
in vivo diffusion and relatively short-term bioactivity. Local gene therapy of BMPs has 
the potential to induce sustained and relatively high level of BMP production at sites 
requiring bone formation. 
 
A three-dimensional microenvironment is necessary to promote the differentiation of 
BMSCs into osteoblasts. The silk fibroin scaffolds have high mechanical strength, are 
easy to handle, are conducive for cell proliferation and have already been used for bone 
tissue engineering[6-9]. When used for cell culture a number of scaffold design 
parameters influence the transport of nutrients and metabolic waste products, such as the 
macroscopic shape of the scaffold, pore size, porosity, pore interconnectivity, pore 
orientation, and surface chemistry. These parameters therefore need to be optimized to 
promote tissue formation in 3D constructs[10,11]. 
 
Previously we have shown that adenovirus vector encoding BMP7 (AdBMP7) can 
enhance bone regeneration around dental implant[12]. In the present study, we 
investigated whether osteoblastic differentiation of the BMSCs expressing BMP7 
influenced by different pore microstructure of silk fibroin scaffolds in vitro. 
 
2. Materials and methods 
2.1.Materials  
MTS was purchased from Promege Chemical Com. Dulbecco’s Modified Eagle’s 
Medium (DMEM) and fetal bovine serum (FBS) were from Gibco Company (Gibco 
BRL/Life Technologies, Victoria, Australia). All other reagents were of analytical grade.  
Silk protein fibroin was extracted from mulberry silk cocoons following a standard 
extraction procedures[13]. Briefly, cocoons were cut into small pieces of approximately 
1 cm × 1 cm dimensions. They were boiled in an aqueous solution of 0.02 M Na2CO3 for 
half an hour (around 10% w/v of silk cocoons and Na2CO3) to remove all traces of 
sericin for complete degumming of the shells. The cocoon pieces were subsequently 
washed thoroughly in distilled water and dried briefly for 1 h at 50°C. Degummed shell 
pieces were dissolved in 9.3 M lithium bromide for 4 h at 60 °C and then centrifuged to 
remove the insoluble material. The supernatant was dialyzed extensively for 3 days 
against deionized water with frequent changes. The protein concentration was then 
measured using BCA protein assay (Progen, Australia) procedure[14]. 
Recombinant adenoviruses were created using the Ad-Easy system (Stratagene, La Jolla, 
CA). Production and purification of the recombinant viruses (Ad-BMP7) were performed 
as described in detail by He et al[15]. Viral titers were estimated by optical density and 
the standard plaque assay. Using these methods preparations of 2 ×1010 particles/ml were 
obtained.   
 
2.2. 3D silk fibroin protein scaffold fabrication 
 
Porous 3D silk fibroin scaffolds were prepared by pouring regenerated viscous silk 
solutions (1–6 wt%) into plastic petri dishes, which were first cooled to 4ºC for half an 
hour, and then immediately transferred to a freezer at -35ºC overnight to solidify the 
solvent and induce solid–liquid phase separation. The solidified mixture was maintained 
at -80ºC for 2 hr and was transferred into a freeze-drying vessel (OHRIST BETA 1-15, 
Germany) for 48 hr until dry, after which the dried samples were treated with 70% (v/v) 
ethanol for 12 hr to induce crystallization and sterilization. The resulting silk scaffolds 
were washed repeatedly with sterile PBS in a biosafety hood to remove any residual 
alcohol before cell culture.  
Scaffolds were divided into four groups according to silk content: 1 wt% silk fibroin 
scaffolds (1 wt%); 2 wt% silk fibroin scaffolds (2 wt%); 3.5 wt% silk fibroin scaffolds 
(3.5 wt%); and 5 wt% (5 wt% ) silk fibroin scaffolds. 
 
2.3. Porosity measurements 
 
The porosity values of the scaffolds were measured by liquid displacement, similar to a 
previously described method[16]. Briefly, scaffolds were cut into 5×5×1 mm pieces, and 
then were placed in a 10 mL cylinder containing a defined volume of ethanol (V1) and 
then pressed to force air out of the scaffold until all trapped air had been evacuated. The 
total volume of ethanol and the ethanol impregnated scaffold was recorded as V2. The 
ethanol impregnated scaffold was removed from the cylinder and the residual ethanol 
volume was recorded as V3. The porosity of the scaffold was expressed as:  
 Porosity = (V1 − V3) / (V2 − V3) 
 
2.4 Human bone marrow stem cells (BMSC) culture and Ad-BMP7 infection 
 
BMSCs were isolated and cultured as previously described [17]. Human BMSCs 
(passage 4) were cultured in cell culture flasks in DMEM supplemented with 10% FBS at 
37 °C with 5% CO2. For infection, cells were seeded at 20,000 cells/cm2 and allowed to 
adhere overnight. Then cells were infected at specified multiplicity（MOI=100）in serum 
free medium by the recombinant viruses (Ad-BMP7). After 6 hr the medium was changed 
to BMSC culture medium mentioned above and cells were kept overnight. The 
expression of BMP7 in infected BMSCs was confirmed by the green fluorescent protein 
(GFP) expression monitored by fluorescent microscope and western blot [12].  
 
2.5. Cell proliferation on silk fibroin 3D scaffolds 
 
Scaffolds were cut into 5×5×1 mm pieces, transferred into 96-well plastic culture and 
incubated in serum free DMEM overnight, then 50 μL cell suspensions with a total of 
1x105 BMSCs were placed onto each scaffold. The cells were allowed to adhere to the 
scaffolds for 3 hr, and then the cell–scaffold complexes were covered with 150 μL of 
culture medium (DMEM + 10%FBS). The cells were incubated for 3 and 7 days and then 
the medium was replaced with 100μL PBS and 20μL of CellTiter 96 Aqueous One 
Solution Reagent (Promega, Genesearch. QLD, Australia).  Then the cell viability was 
determined by measuring the absorbance at 490nm using a 550 BioRad plate-reader 
(Bio-Rad, Hertfordshire, UK) by MTS method. The 7 day incubated scaffolds were also 
fixed in 2.5% glutaraldehyde for confocal microscopy. Scaffolds sections with cells were 
made at a distance of 100 µm from the scaffold surface and scanned by taking 30 Z 
sections of 10 μm each. The Z sections were clubbed together to form a composite image 
for analysis. 
 
2.6 Scanning electron microscopy (SEM) examination  
 
The porous structures of the scaffolds were studied by scanning electron microscopy 
(SEM, Hitachi X-650). Human BMSCs expressing BMP7 were cultured for 1 and 7 days 
on the scaffolds, then fixed on with 2.5% glutaraldehyde in 0.1 mol L-1 sodium 
cacodylate buffer (pH 7.3) for 3 hr at room temperature, rinsed three times with PBS, and 
dehydrated in a grade ethanol series. Samples were then critically point dried, coated with 
gold, and observed by SEM. 
 
2.7. Alkaline phosphatase (ALP) activity of BMSCs 
 
Osteogenic differentiation was assessed by measuring a time course of alkaline 
phosphatase (ALP) activity of the BMSCs grown on the various scaffold types. Scaffolds 
were cut into 5×5×1 mm pieces and transferred into 96-well plastic culture plates and a 
total of 1x105 BMP7 expressing BMSCs were placed onto each scaffold. After 1 day the 
medium was changed to osteogenic differentiation medium containing high glucose 
DMEM containing 10% FBS, 50 μM ascorbic acid 2-phosphate, 10 mM β-glycerol 
phosphate and 100 nM dexamethasone (Sigma Aldrich, Castle Hill, NSW, Australia), 
which was changed every 4 days. On days 7 and 14 samples were removed and ALP 
activity was measured. The scaffold were irrigated with PBS three times to remove as 
much residual serum as possible and then 1 mL of 0.02% Triton® X-100 were placed on 
the scaffold sample to dissolve the cells. The solution was transferred into a 1.5 mL tube, 
and then sonicated. The samples were centrifuged at 14,000 rpm at 4°C for 15 min, and 
the supernatant transferred to fresh1.5 mL tubes to which 100 µL 1 mol/L Tris-HCl, 20 
µL 5 mmol/L MgCl2, and 20 µL 5 mmol/L p-nitrophenyl phosphate was added. After 30 
min incubation at 37°C the reaction was stopped by the addition of 50 µL of 1N NaOH. 
Using p-nitrophenol as a standard, we measured the optical density at 410 nm with a 
spectrophotometer. The ALP activity was expressed as the value of p-nitrophenol 
production quantity divided by the reaction time and the protein synthesis quantity, as 
measured by the BCA Protein assay kit (Thermo Scientific, Melbourne, Australia). The 
ALP activity in BMSCs without transfection of BMP7 in undifferentiated culture was 
used as blank control. ALP activity in BMSCs without transfection of BMP7 seeded on 
3.5wt% silk scaffold in differentiated culture was used as BMP negative control and 
named as BMP(-). 
 
2.8. Reserve transcription and real-time quantitative RT-PCR analysis  
 
The osteoblastic differentiation was further assessed by real-time quantitative RT-PCR 
(RT-qPCR) measuring the expression of ALP, type I collagen (COL1) and osteocalcin 
(OCN) in all treatment groups. Scaffolds were cut into 8×8×2 mm pieces and transferred 
into 24-well plastic culture plates and a total of 106 BMP7 expressing MSCs were placed 
onto each scaffold. The medium were changed after 24 hours to osteogenic 
differentiation medium which was changed every 4 days. On day 14 the samples were 
removed and total RNA isolated using Tri-Reagent® (Sigma Aldrich) according to the 
manufacturer’s protocol. Complementary DNA was synthesized from 1 µg of total RNA 
using SuperScript III (Invitrogen) following the manufacturer’s protocol.  RT-qPCR was 
performed in 25 µl reactions containing 12.5 µl SYBR green Master Mix (Applied 
Biosystems), 2.5 µl (10 µM) of each forward and reverse primer for each gene of interest 
for a final concentration of 20 pmol, 2.5 µl of cDNA template and RNA free water. 
Reactions were performed in triplicates to determine the expression of genes using 
primers (Table I) for ALP, COL1, and OCN. The house keeping gene, 18S rRNA was 
used as a control. The reaction was carried out using ABI Prism 7000 Sequence Detection 
System (Applied Biosystems) and the PCR amplification followed 1 cycle of 10 min at 
95°C, 40 cycles of 15 s at 95 and 60°C for 1 min. Melting curve analysis was performed 
to validate specific amplicon amplification without genomic DNA contamination. 
Relative expression levels for each gene were normalized by the Ct value of the house 
keeping gene 18S rRNA and determined by using the △Ct method The relative expression 
of each gene was analysed by one-way ANOVA and Student–Newman–Keuls (SNK) 
q-test. The significant difference was considered at P<0.05. The mRNA expression in 
BMSCs without transfection of BMP7 in undifferentiated culture was used as blank 
control. The mRNA expression in BMSCs without transfection of BMP7 seeded on 
3.5wt% silk scaffold in differentiation culture was used as BMP negative control and 
named as BMP(-) group. 
 
2.9. Transplantation into calvarial defects 
The bone forming ability of the silk fibroin scaffolds carrying BMP7-expressing MSCs 
was assessed in a calvarial defect model in severe combined immunodeficient (SCID) 
mice[18]. 3.5wt% scaffolds were chosen for this purpose due to the improved 
compression strength compared to the 1%wt scaffolds (results shown in the 
supplemented data). The scaffolds were cut into 3×3×1 mm pieces, transferred into 
24-well plastic culture plates and a total of 1x105 BMSCs expressing BMP7 was placed 
on each scaffold. After 24 hr incubation the medium were changed to osteogenic 
induction medium which was changed every 4 days. On days 14 the complexes were 
implanted into the induced bone defects of the mice. 
The surgeries were carried out according to the guidelines of the Animal Research and 
Care Committee of the Herston Medical Centre and Queensland University of 
Technology.  The surgical procedures were performed in aseptic conditions under 
general inhalation anesthesia. Briefly, a linear incision (1 cm long) was made in the left 
skull to reveal the bone surface. The periosteum was dissected from the bone surface and 
a full-thickness calvarial bone defect, 3 mm in diameter, was created with a trephine bur 
in a slow-speed dental drill. To prevent heating injuries to the animals, 0.9% 
physiological saline was dropped onto the contact point between the bur and bone and 
care was taken to avoid injury to the dura in all animals. The implant was trimmed to fit 
the defect and placed precisely into the defects, and soft tissue above the defect was 
closed with skin staples. Control sites included calvarial defects that did not receive any 
filling material, sites filled with silk fibroin scaffold alone, and sites filled with fibronin 
scaffold seeded with BMSCs without transfection of BMP7. 
Animals were euthanized 4 weeks after surgery and the defect areas were collected. After 
the samples were fixed in 4% paraformaldehyde for 12 hr at room temperature and then 
the tissues were decalcified in 10% EDTA, which was changed twice weekly, for 2 to 3 
weeks, and then embedded in paraffin. Serial sections of 5 m were cut and mounted on 
polylysine-coated slides. All sections were stained with hematoxylin and eosin for 
general assessment of the tissue and wound healing. New bone formation was confirmed 
by immunohistochemical staining using monoclonal anti-human type I collagen (COL1) 
antibody (Sigma-Aldrich, St. Louis, MO) [18]. Specimens were examined with light 
microscope. 
 2.10. Statistical analysis 
All experiments were carried out in triplicate, with each treatment also conducted in 
triplicate. Means and standard deviations (SD) were calculated, and the statistical 
significance of differences among each group was examined by one-way ANOVA and a 
Post hoc t-test. The significance was set at p<0.05 level. 
 
3. Results  
3.1 Scaffold morphology 
 
High porosity silk scaffolds were prepared by solid–liquid phase separation. Fig. 1 shows 
the SEM examinations of the scaffolds and clearly demonstrated that the pore size 
decreases with increasing silk concentration. The range of pore size estimated from the 
SEM measurement is presented in Table 2. The porosity and average pore diameter 
decreased with the increase of silk fibroin solution concentration, 
 
After 1 day of seeding, SEM images showed that cells had a uniform distribution in the 
scaffolds. Although cell density was low and the cells appeared to be flat. After one 
week’s culture the cell density increased obviously in all four types of scaffolds compared 
to that at Day 1. (Fig. 1).  
 
3.2 MTS assay 
 
MTS assay was adopted to evaluate the cytotoxicity of the tissue-engineering 
materials. The BMSCs attached uniformly to all scaffolds with different pore size after 
one day of culture and the cell density increased proportionally with time in culture (Fig. 
2). The data indicated that the percent of viable cells on 5wt% scaffold were significantly 
lower than that on other scaffolds in the same culture period (P<0.05), suggesting that 
MSCs proliferation decreased on the 5wt% scaffold compared with the other three types 
of scaffolds.  
Three days after infection with AdEasy-1 gene at a MOI of 100, GFP expression 
showed around 80% bMSCs were infected. The cell migration in silk scaffolds was 
investigated by confocal laser microscopy (CLM). It was noted that BMSCs attached and 
migrated into the pore areas of all types of scaffolds. Inside the scaffold (100 m from 
the surface) large amount of cells were detected with more cells in 3.5wt% scaffold and 
less cells in 5wt% scaffold. GFP expression revealed that the cells grew into the pores of 
scaffolds. Cells adhered to the pore walls and spread well (Fig.3). 
 
3.3 ALP assay 
 
To determine osteogenic differentiation of the BMSCs on the various scaffolds, 
endogenous alkaline phosphatase (ALP) were evaluated on days 7 and 14. All groups 
showed a continuous increase of ALP activity over the in vitro culture period. 3.5wt% 
scaffold, in particular, exhibited significantly higher ALP activity (P<0.05) after 7 days 
of culture compared with 5wt% scaffold. Compared with undifferentiated BMSCs, 
osteogenic differentiation culture resulted in significant upregulation of ALP activity. The 
ALP activity was also significantly higher in BMSCs transfected with BMP7 compared 
with BMSCs without Ad-BMP7 infection cultured in silk scaffold. On day 14, ALP level 
was slightly lower in 5wt% scaffold compared with the other three groups. There were, 
however, no significant differences between 1wt%, 2wt% and 3.5wt% scaffolds (Fig. 4).  
 
3.4 Real time quantitative RT-PCR 
 
The osteoblastic differentiation was further assessed by measuring the mRNA expression 
of alkaline phosphatase (ALP), type I collagen (COL1) and osteocalcin (OCN) by 
RT-qPCR (Fig. 5). After 2 weeks osteogenic culture all three osteogenic markers were 
significantly upregulated in BMSCs expressing BMP7 on all four types of silk scaffolds 
compared to the controls of either undifferentiated BMSCs or differentiated BMSCs 
without BMP7 infection on silk scaffolds. Variations in the mRNA expression level of 
these markers was detected in each individual sample; on 5wt% scaffold, for example, 
had less mRNA expression of ALP, COL1 and OCN than the cells on other type of 
scaffolds.  However, with the exception of 3.5wt% scaffold compared with 5wt% 
scaffold, there was no statistically significant difference in the gene expression between 
groups after 14 days of osteogenic induction, when the samples (n=4) were averaged and 
normalized against the house keeping gene  (p>0.05) (Fig. 5).  
 
3.5 In vivo study 
 
There was no histological evidence of an inflammatory reaction in any of the treatment 
groups four weeks after implantation (Fig. 6). Unfilled calvarial defects were covered 
with a thin fibrous connective tissue sheet with no evidence of new bone formation. Bone 
defects filled with silk fibroin scaffold alone showed increased amounts of cells and 
fibrous tissue within the defects and no detectable new bone formation. In the group of 
defect filled with silk scaffold with BMSCs without BMP infection, some new bone 
formation was detected close to the edge of bone defect, but no new bone formation was 
detected in the central of the defects. New bone formation was found in defects filled 
with silk fibroin scaffolds seeded with BMP7 expressing BMSCs. Some bone islands 
formed inside silk fibroin scaffolds, not only close to the bone defects, but also in the 
central of the defect. In addition, mineralized bony trabeculae were found and these were 
surrounded by osteoblasts. The levels of COL1 expression in silk fibroin scaffolds were 
determined by immunohistochemical methods (Fig. 5). COL1 expression was located to 
bone matrix and newly formed osteoid, osteoblasts and their matrices, as well as around 
the silk fibroin fibers (Fig. 5).  
 
Discussion 
 
Pore architecture of scaffolds is known to play a critical role in tissue engineering as it 
provides the vital framework for the seeded cells to organize into a functioning tissue. 
This study demonstrated that BMSCs expressing BMP7 gene were able to proliferate and 
differentiate when seeded and cultured within various pore architectures of silk fibroin 
scaffolds and also that BMSCs-BMP7/scaffold complexes, implanted into critical-size 
defects in SCID mouse calvaria, were capable of inducing new bone formation. 
 
In this study we controlled concentration of silk fibroin protein to fabricate different 3D 
scaffold pore microstructure. Four pore size ranges of silk fibroin scaffolds were made by 
a freeze-dry technique, with pore sizes ranging from 50 to 300 µm; the pore sizes 
decreasing as the silk concentration increased. To evaluate what effects the pore 
architecture of silk fibroin scaffolds had on BMSC attachment and proliferation, cells 
were seeded on the silk fibroin scaffolds. Localization and viability of the cells were 
analyzed by SEM and confocal microscopy. Cells attached to the surface of all four 
porosity groups and proliferated over 14 days in culture. The cell proliferation and 
distribution 1wt%, 2wt%, and 3.5wt% scaffolds were equal, whereas proliferation of cells 
seeded on 5wt% scaffold was reduced. The cell morphology, proliferation and migration 
on the silk scaffolds indicated all surfaces were cytocompatible.  
 
There is no general consensus as to the optimal pore size for cell growth and tissue 
formation. An effective pore size range of 200–400 µm has been reported for bone 
formation [19], while others found no selectivity of osteoblasts for pore sizes in the range 
of 150–710 μm[20]. Hulbert et al. found that bone regeneration in scaffolds with pore 
sizes smaller than 350 μm is variable, pore sizes between 100 and 200 µm resulted in 
bone in-growth, while pore sizes between 10 and 100 μm resulted in fibrous tissue or 
unmineralized osteoid in-growth[15]. Zeltinger et al. found that vascular smooth muscle 
cells showed equal cell proliferation and extracellular matrix formation in pores ranging 
in size from  38 to 150 μm [21], whereas Min et al found that scaffold pore size 
rangeing from 50 to 200 μm did not significantly affect smooth muscle cells growth[22]. 
These findings are consistent with our observations for pore sizes ranging from 100 to 
300 μm, in which we found that BMSCs proliferation and ECM production were 
unaffected. The cell proliferation and ECM production decreased however when the pore 
size was in the 50-100 μm range, which may be the result of less cells initially attaching 
to these finer pore structures. 
 
The effect of pore architecture of silk fibroin scaffolds on MSC differentiation was 
assessed by several assays, including alkaline phosphatase activity, which is an indicator 
of osteogenic differentiation, bone formation, and matrix mineralization. Previous studies 
have demonstrated that scaffold pore architecture affects ALP activity [23]. Our results 
showed that ALP activity increased on all four surface structures compared with control, 
suggesting that differentiation and maturation of BMSCs to the osteoblastic phenotype 
had indeed taken place (Fig. 4). There was no significant difference in ALP activity 
between groups with the exception of 5wt% scaffold, which was lower compared to the 
other groups.  
 
Real time quantitative PCR of osteoblast differentiation marker genes confirmed such 
phenotype change of the BMSCs with BMP expression on the scaffolds (Fig. 5). It was 
clearly seen that the expressions of all three osteogenic genes increased significantly in 
all silk scaffold groups compared with the controls of either undifferentiated BMSCs or 
BMScs without BMP7 transfection on the 3.5wt% scaffold. These results suggest that 
porous silk fibroin scaffolds are capable of providing an environment suitable for 
osteogenesis of human mesenchymal stem cells expressing BMP7 gene. 
 
In the present study, critical-size defects were created in mouse calvaria. This model of 
bone repair has been used to study new bone formation in many studies [18,24]. An 
implant must contain a relatively high number of progenitor or differentiated cells, as 
well as bioactive factors to specifically attract reparative cells to the injury sites [25]. We 
identified new bone formation in the defect site and the formation of isolated bone islands 
in the silk fibroin scaffold, whereas little or no bone formation was found in the negative 
controls. These findings are consistent with other studies, which showed that implants 
containing differentiated MSCs and developed matrices are involved in direct bone 
formation, and also appear to be osteoconductive during the repair of the critical-size 
bone defects [26,27].  
 
5. Conclusions 
In this study we showed that porous architecture of silk fibroin scaffolds in optimized 
porosity can support BMP7 expressing BMSCs delivery, facilitate ostegenic 
differentiation, and induce new bone formation.  
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 Figure legend： 
Fig. 1 shows SEM micrographs of the scaffolds. (A, E, I) 1 wt% silk fibroin scaffolds; (B, 
F, J) 2 wt% silk fibroin scaffolds; (C, G, K) 3.5 wt% silk fibroin scaffolds; (D, H, L) 5 
wt% silk fibroin scaffolds; (A, B, C, D) represents the scaffolds without cell seeding. At 
day 1 after seeding cells were evenly distributed inside the scaffolds, although cell 
numbers were low and the cells appeared to have a flat morphology (E, F, G, H). No 
differences were noted among the four scaffold types; One week after seeding the number 
of cells had significantly increased in all four scaffold types compared to day 1 after cell 
seeding (I, J, K, L). 
 
FIG 2. The proliferation of human MSCs on the four scaffolds porosity groups was 
determined by an MTS assay. The viable cell percentage on 3.5 wt% silk fibroin scaffolds 
was significantly higher than those on 1 wt% silk fibroin scaffolds. In 5 wt% silk fibroin 
scaffolds, cells showed the lowest proliferation rate, which was statistically significant 
compared to other groups. (*P<0.05). 
 
FIG 3.  The 7 day incubated scaffolds with BMP7 expressing BMSCs. Confocal laser 
microscopy revealed that GFP-positive cells were adhered and spread in the middle of the 
scaffolds (Bar: 150 μm). (A) 1wt% silk fibroin scaffolds; (B) 2 wt% silk fibroin scaffolds; 
(C) 3.5 wt% silk fibroin scaffolds; (D)  5 wt% silk fibroin scaffolds. 
 
FIG 4. All groups showed a continuous increase of in vitro ALP activity over the culture 
period. 3.5 wt% silk fibroin scaffolds had significantly higher ALP activity after one week 
of osteogenic culture compared with the other scaffolds. On day 14, minimal ALP was 
present within 5 wt% silk fibroin scaffolds; there was, however, no significant differences 
between other groups (*P<0.05). Blank: BMSCs in undifferentiation culture. BMP(-): 
BMSCs without BMP7 infection in 3.5wt% silk scaffold.  
 
FIG. 5. The osteoblastic phenotype was assessed by measuring the expression of alkaline 
phosphatase (ALP), type I collagen (COL1) and osteocalcin (OCN) by real-time 
quantitative PCR in all groups. The mRNA expression of ALP, COL1, and OCN was 
normalized against 18s. There was a significant upregulation of ALP, COL1, and OCN 
mRNAs in MSCs cultured in three-dimensional silk fibroin scaffolds in mineralized 
culture medium. Blank: BMSCs in undifferentiation culture. BMP(-): BMSCs without 
BMP7 infection in 3.5wt% silk scaffold.  
 
FIG. 6. There was no histological evidence of an inflammatory reaction in any of the 
treatment groups 4 weeks after implantation in an induced calvarial defect in SCID mice. 
(A) hematoxylin and eosin image of control, scale bar : 100µm; (B) Sections were stained 
with monoclonal anti-human type I collagen antibody scale bar: 100µm; (C) Sections were 
stained with monoclonal anti-human type I collagen antibody scale bar : 20µm; (D) 
hematoxylin and eosin image of 3.5 wt% silk fibroin scaffolds without BMSCs, scale bar: 
100µm; (E) Sections were stained with monoclonal anti-human type I collagen antibody 
scale bar : 100µm; (F) Sections were stained with monoclonal anti-human type I collagen 
antibody scale bar : 20µm; Arrowheads show fibrils of silk fibroin scaffolds. (G) 
hematoxylin and eosin image of 3.5 wt% silk fibroin scaffolds with BMP7 expressing 
BMSCs, scale bar: 100µm; (H) Sections were stained with monoclonal anti-human type I 
collagen antibody scale bar : 100µm; (I) Sections were stained with monoclonal 
anti-human type I collagen antibody scale bar : 20µm. Arrowheads show fibrils of silk 
fibroin scaffolds and NB show the new bone. (J) hematoxylin and eosin image of 3.5 wt% 
silk fibroin scaffolds with BMSCs without BMP7 infection, scale bar: 100µm; (K) 
Sections were stained with monoclonal anti-human type I collagen antibody scale bar : 
100µm; (L) Sections were stained with monoclonal anti-human type I collagen antibody 
scale bar : 20µm. Arrowheads show fibrils of silk fibroin scaffolds and NB show the new 
bone. 
